Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Apr 3, 2014 | Neurovance | Series A | — | Biotechnology | — |
Mar 1, 2013 | CardioKinetix | Series E | — | Biotechnology | — |
Jan 8, 2013 | Labcyte | Series D | — | Alternative Medicine | — |
Oct 18, 2012 | Neurovance | Series Unknown | — | Biotechnology | — |
Oct 5, 2011 | Puma Biotechnology | Post-IPO Equity | — | Biotechnology | — |
Aug 4, 2008 | PHT Corporation | Series F | — | Clinical Trials | — |
Mar 1, 2004 | CardioNet | Series D | — | Biotechnology | — |
Oct 2, 2003 | PHT Corporation | Series E | — | Clinical Trials | — |
Oct 30, 2001 | Therion Biologics | Series Unknown | — | Biotechnology | — |
Jun 20, 2000 | Acadia Pharmaceuticals Inc. | Debt Financing | — | Biotechnology | Yes |